Pancreatic Cancer Research

ResearcherBeijing University of Chinese MedicineActive in the last 2 years

Xia Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6068-5182; OpenAlex author ID A5100445583. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. Harmine suppresses pancreatic cancer through DYRK1A-mediated hyper-activated RAS/MAPK inhibition. Co-author DOI 10.1016/j.bcp.2025.117291↗
  2. Direct regulation of FNIP1 and FNIP2 by MEF2 sustains MTORC1 activation and tumor progression in pancreatic cancer. Co-author DOI 10.1080/15548627.2023.2259735↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cen Liu · 1 shared paper, 2025 · strength 0.27
  2. Yonggang Liu · 1 shared paper, 2025 · strength 0.27
  3. Qian Yang · 1 shared paper, 2024 · strength 0.19
  4. Xiaobin Li · 1 shared paper, 2024 · strength 0.19
  5. Qing Wang · 1 shared paper, 2024 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.